Caorui Lin

444 citations

24 papers · 314 · h-index 10

Impact in

Cancer Research
- MicroRNA in disease regulation
Molecular Biology
- Extracellular vesicles in disease
- Muscle Physiology and Disorders
- RNA Interference and Gene Delivery

Papers in

Molecular Biology 10
- Muscle Physiology and Disorders 8
- RNA Interference and Gene Delivery 4
- Extracellular vesicles in disease 3
Epidemiology 8
- Hepatitis B Virus Studies 8
- Liver Disease Diagnosis and Treatment 5

Co-authors: HaiFang Yin (11 shared papers)Ning Ran (7 shared papers)Xianjun Gao (4 shared papers)Mengyuan Geng (3 shared papers)Gang Han (9 shared papers)Xue Dong (1 shared paper)Junjin Li (1 shared paper)Qishui Ou (10 shared papers)
Journals: Molecular Therapy — Nucleic Acids (3 papers)Biomaterials (2 papers)Gut (2 papers)EMBO Molecular Medicine (2 papers)Bioactive Materials (1 paper)
Partner nations: China Singapore United States

In The Last Decade

Caorui Lin

22 papers receiving 309 citations

Peers

Countries citing papers authored by Caorui Lin

Since Specialization

Citations

This map shows the geographic impact of Caorui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caorui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caorui Lin more than expected).

Fields of papers citing papers by Caorui Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caorui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caorui Lin. The network helps show where Caorui Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Caorui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Caorui Lin Line = papers co-authored together Caorui Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice Biomaterials ·Ning Ran, Xianjun Gao, Xue Dong, Junjin Li, Caorui Lin, Mengyuan Geng, HaiFang Yin	2020	85
2	Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury Bioactive Materials ·Ning Ran, Wenxiang Li, Renjie Zhang, Caorui Lin, Jianping Zhang, Zhijian Wei, Zonghao Li, Zhongze Yuan, Min Wang, Baoyou Fan, Wenyuan Shen, Xueying Li, Hengxing Zhou, Xue Yao, Xiaohong Kong, Shiqing Feng	2022	53
3	Glycine Enhances Satellite Cell Proliferation, Cell Transplantation, and Oligonucleotide Efficacy in Dystrophic Muscle Molecular Therapy ·Caorui Lin, Gang Han, Hanhan Ning, Jun Song, Ning Ran, Xianfu Yi, Yiqi Seow, HaiFang Yin	2020	34
4	Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury Gut Microbes ·Li Zhang, Zhiyi Zheng, Huanhuan Huang, Ya Fu, Tianbin Chen, Can Liu, Qiang Yi, Caorui Lin, Yongjun Zeng, (unknown), Qishui Ou, Yongbin Zeng	2024	21
5	Fructose Promotes Uptake and Activity of Oligonucleotides With Different Chemistries in a Context-dependent Manner in mdx Mice Molecular Therapy — Nucleic Acids ·Limin Cao, Gang Han, Caorui Lin, Ben J. Gu, Xianjun Gao, Hong M. Moulton, Yiqi Seow, HaiFang Yin	2016	16
6	Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes EMBO Molecular Medicine ·Gang Han, Yao Zhang, Zhong Li, Biaobiao Wang, Shuai Qiu, Jun Song, Caorui Lin, Fangdi Zou, Jingqiao Wu, Huanan Yu, Chao Liang, Ke Wen, Yiqi Seow, HaiFang Yin	2024	13
7	Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach Materials Today Bio ·Zhen Xun, Xiaobao Yao, Chenggong Zhu, Yuchen Ye, Songhang Wu, Tianbin Chen, Yongbin Zeng, Caorui Lin, Bin Yang, Qishui Ou, Can Liu	2022	12
8	MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice EMBO Molecular Medicine ·Ning Ran, Caorui Lin, Ling Leng, Gang Han, Mengyuan Geng, Yingjie Wu, Scott Bittner, Hong M. Moulton, HaiFang Yin	2020	11
9	Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infection Gut ·Caorui Lin, Linjie Luo, Zhen Xun, Chenggong Zhu, Ying Huang, Yuchen Ye, Jiawei Zhang, Tianbin Chen, Songhang Wu, Fuguo Zhan, Bin Yang, Can Liu, Ning Ran, Qishui Ou	2023	10
10	Long-Term Morpholino Oligomers in Hexose Elicit Long-Lasting Therapeutic Improvements in mdx Mice Molecular Therapy — Nucleic Acids ·Gang Han, Caorui Lin, Hanhan Ning, Xianjun Gao, HaiFang Yin	2018	10
11	Upregulation of Wilms’ Tumor 1 in epicardial cells increases cardiac fibrosis in dystrophic mice Cell Death and Differentiation ·Zhenglong Guo, Mengyuan Geng, Yuting Huang, Gang Han, Renwei Jing, Caorui Lin, Xiaoning Zhang, Miaomiao Zhang, Guanwei Fan, Feng Wang, HaiFang Yin	2022	8
12	Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression Frontiers in Immunology ·Caorui Lin, Ying Huang, Linjie Luo, Fengling Fang, Jiawei Zhang, Zhen Xun, Ya Fu, Hongyan Shang, Can Liu, Qishui Ou	2022	7
13	Hexose Potentiates Peptide-Conjugated Morpholino Oligomer Efficacy in Cardiac Muscles of Dystrophic Mice in an Age-Dependent Manner Molecular Therapy — Nucleic Acids ·Gang Han, Ben J. Gu, Caorui Lin, Hanhan Ning, Jun Song, Xianjun Gao, Hong M. Moulton, HaiFang Yin	2019	7
14	Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling Cellular and Molecular Gastroenterology and Hepatology ·Yuchen Ye, FU Ya, Caorui Lin, Ye Shen, Qingqing Yu, Xiaobao Yao, Qunfang Huang, Can Liu, Yongbin Zeng, Tianbin Chen, Songhang Wu, Zhen Xun, Qishui Ou	2023	7
15	Emerging role of mitochondria in response to HBV infection Journal of Clinical Laboratory Analysis ·Caorui Lin, Qishui Ou	2022	6
16	Cardio‐respiratory and phenotypic rescue of dystrophin/utrophin‐deficient mice by combination therapy EMBO Reports ·Caorui Lin, Gang Han, Lulu Jia, Yiwen Zhao, Jun Song, Ning Ran, Toshifumi Yokota, Yiqi Seow, HaiFang Yin	2022	5
17	A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B Microbiology Spectrum ·Long Wang, Lin Ni, Yanfang Zhang, Shaoying Guo, Can Liu, Caorui Lin, Yongbin Zeng, Wennan Wu, Jianhui Guo, Chenggong Zhu, Fuguo Zhan, Qishui Ou, Zhen Xun	2023	3
18	Nomogram Model for Prediction of SARS-CoV-2 Breakthrough Infection in Fujian: A Case–Control Real-World Study Frontiers in Cellular and Infection Microbiology ·Tianbin Chen, Yongbin Zeng, Di Yang, Wenjing Ye, Jiawei Zhang, Caorui Lin, Yihao Huang, Yucheng Ye, Jianwen Li, Qishui Ou, Jinming Li, Can Liu	2022	2
19	Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α Gut ·Caorui Lin, Ying Huang, Ning Ran, Jie Liu, Linjie Luo, Xin Zhang, (unknown), Zhen Xun, Siyi Xu, Can Liu, Xiaohong Kong, Shiqing Feng, Haiting Mao, Qishui Ou	2025	1
20	Characterization of BCP/PreC/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencing International Journal of Medical Microbiology ·Chenggong Zhu, (unknown), Ya Fu, Zhen Xun, Caorui Lin, Songhang Wu, Tianbin Chen, Yongbin Zeng, Bin Yang, Qishui Ou, Can Liu	2024	1

About Caorui Lin

Caorui Lin is a scholar working on Molecular Biology, Epidemiology, Surgery, Hepatology and Rheumatology, having authored 24 papers that have together received 314 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (8 papers), Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (5 papers), RNA Interference and Gene Delivery (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Hepatitis C virus research (3 papers), Extracellular vesicles in disease (3 papers) and Telomeres, Telomerase, and Senescence (2 papers). The work is most often cited by research in Cancer Research (53 citations), Molecular Biology (210 citations), Aging (5 citations), Hepatology (14 citations) and Genetics (17 citations). Caorui Lin has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include HaiFang Yin, Ning Ran, Xianjun Gao, Mengyuan Geng, Gang Han, Xue Dong, Junjin Li, Qishui Ou, Yiqi Seow and Yongbin Zeng. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Biomaterials, Gut, EMBO Molecular Medicine and Bioactive Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Caorui Lin

Impact in

Papers in i

In The Last Decade

Caorui Lin

Peers

Countries citing papers authored by Caorui Lin

Fields of papers citing papers by Caorui Lin

All Works

About Caorui Lin

Explore authors with similar magnitude of impact

Papers in